follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Christie joins Zoetis execs to celebrate company's independence from Pfizer

By

Back to Top Comments Email Print

News You Can Use

Latest News

advertisement
From left, Clint Lewis, Zoetis Inc. executive vice president and president of U.S. operations, Gov. Chris Christie, and Sandra Beaty, executive vice president of corporate affairs, plant a Red Oak tree, the state tree, to celebrate Zoetis laying roots in New Jersey. Zoetis, the former animal health unit of Pfizer Inc., formally christened its Florham Park headquarters today at 100 Campus Drive. It employs about 400 there.
From left, Clint Lewis, Zoetis Inc. executive vice president and president of U.S. operations, Gov. Chris Christie, and Sandra Beaty, executive vice president of corporate affairs, plant a Red Oak tree, the state tree, to celebrate Zoetis laying roots in New Jersey. Zoetis, the former animal health unit of Pfizer Inc., formally christened its Florham Park headquarters today at 100 Campus Drive. It employs about 400 there. - (Zoetis)

Zoetis Inc., the former animal health unit of Pfizer Inc., celebrated its independence as a standalone company today, formally christening its Florham Park headquarters.

Gov. Chris Christie joined the ceremony, planting a red oak tree to acknowledge the company's New Jersey roots, as well as to replace trees lost in Hurricane Sandy.

Christie noted that Zoetis' decision to spin off from Pfizer and plant headquarters in New Jersey builds on the state's strength as a home for animal health businesses. Merck & Co.'s animal health unit is based in Summit, and Phibro Animal Health has its headquarters in Teaneck.

"Our workforce, with its abundant supply of highly skilled scientists, veterinary specialists and skilled professionals is, ideal for Zoetis and well-matched to the demands of the dynamic animal health industry," Christie said in a statement.

Zoetis completed its separation from Pfizer in June upon the completion of an exchange offer. The animal health unit is about 60 years old, but executives said momentum in recent years persuaded Zoetis it would achieve greater value as a standalone company. Zoetis generates $4.3 billion in revenue, making it the largest animal health company in the world.

"We are committed to growing our business in New Jersey where we have access to a highly educated and diverse work force, which is essential to managing a global health company," said Sandra Beaty, Zoetis executive vice president of corporate affairs.

Zoetis decision to spin off came with state-funded incentives. The New Jersey Economic Development Authority awarded the company a $19 million grant on Aug. 14 from its Business Employment Incentive Program.

Under terms of the grant, Zoetis has located about 400 employees at 100 Campus Drive. Employees there support the company's global business functions and its marketing and veterinary technical services operations in the United States and Canada and Latin America.

Zoetis Inc., the former animal health unit of Pfizer Inc., celebrated its independence as a standalone company today, formally christening its Florham Park headquarters.

Gov. Chris Christie joined the ceremony, planting a red oak tree to acknowledge the company's New Jersey roots, as well as to replace trees lost in Hurricane Sandy.

Christie noted that Zoetis' decision to spin off from Pfizer and plant headquarters in New Jersey builds on the state's strength as a home for animal health businesses. Merck & Co.'s animal health unit is based in Summit, and Phibro Animal Health has its headquarters in Teaneck.

"Our workforce, with its abundant supply of highly skilled scientists, veterinary specialists and skilled professionals is, ideal for Zoetis and well-matched to the demands of the dynamic animal health industry," Christie said in a statement.

Zoetis completed its separation from Pfizer in June upon the completion of an exchange offer. The animal health unit is about 60 years old, but executives said momentum in recent years persuaded Zoetis it would achieve greater value as a standalone company. Zoetis generates $4.3 billion in revenue, making it the largest animal health company in the world.

"We are committed to growing our business in New Jersey where we have access to a highly educated and diverse work force, which is essential to managing a global health company," said Sandra Beaty, Zoetis executive vice president of corporate affairs.

Zoetis decision to spin off came with state-funded incentives. The New Jersey Economic Development Authority awarded the company a $19 million grant on Aug. 14 from its Business Employment Incentive Program.

Under terms of the grant, Zoetis has located about 400 employees at 100 Campus Drive. Employees there support the company's global business functions and its marketing and veterinary technical services operations in the United States and Canada and Latin America.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top